Latest Kaiser Health News Stories
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
Amid the buzz over apps and electronic medical records rescuing modern medicine, California’s Medicaid program still clings to 1970s-era technology. A reboot may cost half a billion dollars.
States often get federal approval to test new approaches to improve Medicaid services or expand coverage. But the GAO study found that too often these efforts are not adequately evaluated or the results are not available in a timely manner.
Many women who served in the military decades ago were victims of sexual assaults but often felt compelled to keep quiet.
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
Some Veterans Affairs’ hospitals are cutting vets’ long waits for outpatient care appointments by authorizing specially-trained pharmacists to treat certain patients with chronic care needs.
The changes announced Tuesday seek to eliminate the backlog by 2021.
The Government Accountability Office found bonuses and penalties have been small, and hospital performance has been steady.
Congressional watchdog says the government checks few health plans to ensure accurate provider listings and adequate access for seniors on Medicare Advantage.